Doctors said the yellow nodules were identified as xanthelasma – a skin condition characterized by yellowish, raised deposits of cholesterol typically on or around the eyelids, according to the ...

Supernus Pharmaceuticals has announced the FDA approval of ONAPGO, the first subcutaneous apomorphine infusion ... were infusion-site nodule, nausea, somnolence, infusion-site erythema, dyskinesia ...

Onapgo is the first and only wearable subcutaneous apomorphine infusion ... included infusion-site nodule, nausea, excessive sleepiness, infusion-site skin irritation, headache, and insomnia.

An article published Jan. 22 in the JAMA Network said the man in his 40s visited the doctor after reportedly noticing the skin discoloration for three weeks. The article said the patient adopted a ...